Rossari Biotech Announcements
Rossari Biotech Limited informed the Exchange regarding Press Release dated January 17, 2026 titled " Rossari Biotech announces Q3 FY 26 Results".
19 Jan, 2026 | 11:47am • Source: BSE
Intimation of Q3 & 9M FY26- Earnings Presentation.
18 Jan, 2026 | 04:01pm • Source: BSE
Newspaper Publication of extract of Consolidated Unaudited Financial Results for the quarter and nine months ended December 31, 2025.
18 Jan, 2026 | 03:39pm • Source: BSE
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
17 Jan, 2026 | 04:20pm • Source: BSE
Intimation of allotment of 2000 Equity Shares under Rossari Employee Stock Option Plan- 2019.
17 Jan, 2026 | 04:12pm • Source: BSE
Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2025.
17 Jan, 2026 | 04:07pm • Source: BSE
Outcome of Board Meeting held on January 17, 2026.
17 Jan, 2026 | 03:58pm • Source: BSE
Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/01/2026 ,inter alia, to consider and...
09 Jan, 2026 | 11:23pm • Source: BSE
Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025.
05 Jan, 2026 | 05:10pm • Source: BSE
Rossari Biotech Limited has informed the Exchange regarding the Trading Window Closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
29 Dec, 2025 | 07:14pm • Source: BSE
Incorporation of Rossari (Singapore) Pte. Ltd., in Republic of Singapore, wholly owned subsidiary of Rossari Biotech Limited.
18 Dec, 2025 | 04:21pm • Source: BSE
The Board of Directors have inter alia approved Incorporation of wholly owned subsidiary in Republic of Singapore and other matters
18 Dec, 2025 | 12:21pm • Source: NSE
The Board of Directors have inter alia approved Incorporation of wholly owned subsidiary in Republic of Singapore and other matters.
18 Dec, 2025 | 11:45am • Source: BSE
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015
24 Nov, 2025 | 09:07pm • Source: BSE
Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.
06 Nov, 2025 | 06:36pm • Source: BSE
Intimation of Transcript of Q2 FY 26 for the Earnings Conference Call held on October 17, 2025.
27 Oct, 2025 | 07:35pm • Source: BSE
Audio recording of Earnings Conference call for Q2 FY 26.
17 Oct, 2025 | 06:52pm • Source: BSE
Newspaper Publication of extract of Consolidated Unaudited Financial Results for the quarter and half year ended September 30, 2025.
17 Oct, 2025 | 04:45pm • Source: BSE
Rossari Biotech Limited informed the Exchange regarding Press Release dated October 15, 2025 titled "Rossari Biotech announces Q2 FY 26 Results"
16 Oct, 2025 | 04:44pm • Source: BSE
Intimation of Q2 & H1 FY26 -Earnings Presentation.
16 Oct, 2025 | 04:34pm • Source: BSE